Astrazeneca AZN
NYSE AZN
$163.70 +3.53 (+2.20%)
As of: Sep 14, 2026 · 3:06 PM EDT

Astrazeneca (AZN) Cash from Operations Growth (1y) (2010 - 2026)

Analysis

Astrazeneca (AZN) Cash from Operations Growth (1y) (2010 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Ops. Growth (1y) (Qtr)
1 Asml Holding 618.78 Bn 602.80 Bn 5.90 Bn -
2 Hsbc Holdings 362.62 Bn 362.62 Bn - -
3 General Electric 329.79 Bn 320.45 Bn 6.95 Bn 38.76%
4 Astrazeneca 253.78 Bn 248.49 Bn 12.86 Bn -15.39%
5 Citigroup 228.38 Bn -2,073.93 Bn 24.75 Bn -
6 Bhp 216.07 Bn 197.52 Bn - -
7 Rio Tinto 203.71 Bn 199.33 Bn - -
8 Diageo 197.09 Bn 195.06 Bn - -
9 Unilever 139.31 Bn 132.28 Bn - -
10 Hdfc Bank 117.84 Bn 80.69 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -15.39%
Mar 31, 2026 -9.53%
Dec 31, 2025 -19.44%
Sep 30, 2025 51.76%
Jun 30, 2025 9.76%
Mar 31, 2025 49.36%
Dec 31, 2024 -63.50%
Jun 30, 2024 79.57%
Mar 31, 2024 -20.65%
Dec 31, 2023 7.49%
Jun 30, 2023 37.66%
Mar 31, 2023 -3.06%
Dec 31, 2022 422.57%
Jun 30, 2022 39.91%
Mar 31, 2022 67.11%
Dec 31, 2021 -21.13%
Sep 30, 2021 -5.65%
Jun 30, 2021 -14.23%
Mar 31, 2021 1,291.37%
Dec 31, 2020 266.19%